Jorunn Brekke

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Journal: Clinical and translational radiation oncology

Published: May 03, 2026

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Journal: Clinical and translational radiation oncology

Published: December 09, 2025

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

Journal: NPJ precision oncology

Published: October 14, 2025

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism.

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism.

Journal: Frontiers in oncology

Published: October 31, 2024

A woman in her thirties with confusion.

A woman in her thirties with confusion.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: August 21, 2024

Breaking boundaries: A rare case of glioblastoma with uncommon extraneural metastases: A case report and literature review.

Breaking boundaries: A rare case of glioblastoma with uncommon extraneural metastases: A case report and literature review.

Journal: Brain & spine

Published: July 22, 2024

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Journal: BMJ open

Published: March 20, 2023

Arterial events in cancer patients treated with apixaban for venous thrombosis.

Arterial events in cancer patients treated with apixaban for venous thrombosis.

Journal: Thrombosis research

Published: March 13, 2023

Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.

Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.

Journal: PloS one

Published: August 26, 2022

"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply.

"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 07, 2022

Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up.

Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 02, 2021

Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism.

Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism.

Journal: Thrombosis research

Published: May 29, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026